| Date |
Name  |
Title |
Type |
Shares Traded |
Price Range |
| Jun 28, 2007 |
topper james n |
Director |
Buy |
4,281 |
11.48 - 11.50 |
| Jun 28, 2007 |
topper james n |
Director |
Buy |
4,734 |
11.32 - 11.47 |
| Jun 27, 2007 |
topper james n |
Director |
Buy |
52,788 |
10.95 - 11.23 |
| Jun 27, 2007 |
topper james n |
Director |
Buy |
91,612 |
11.11 - 11.50 |
| Jun 5, 2007 |
topper james n |
Director |
Acquisition (Non Open Market) |
2,600,014 |
n/a |
| May 24, 2011 |
valenzano ken |
Officer |
Option Execute |
2,250 |
0.64 |
| May 24, 2011 |
valenzano ken |
Officer |
Sell |
2,250 |
7.50 |
| May 10, 2010 |
valenzano ken |
Officer |
Statement of Ownership |
0 |
n/a |
| Aug 14, 2008 |
weinhoff gregory m |
Director |
Sell |
50,000 |
17.00 |
| Jun 5, 2007 |
weinhoff gregory m |
Director |
Acquisition (Non Open Market) |
1,975,223 |
n/a |
| May 30, 2007 |
weinhoff gregory m |
Director |
Statement of Ownership |
0 |
n/a |
| Nov 13, 2012 |
winterbottom joan |
Officer |
Buy |
1,665 |
4.54 |
|
|
Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.